Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B

Journal of Comparative Neurology

Volumn 515, Issue 1, 2009, Pages 93-101

  Garbuzova Davis, Svitlana ^a   Klasko, Stephen ^a   Sanberg, Paul K ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cord blood; Intravenous administration; Mice; Sanfilippo syndrome type B

Indexed keywords

ALPHA N ACETYLGLUCOSAMINIDASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL MIGRATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SANFILIPPO SYNDROME; TH2 CELL; WESTERN BLOTTING;

ACETYLGLUCOSAMINIDASE; ANIMALS; BRAIN; CELLS, CULTURED; COGNITION DISORDERS; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERKINESIS; INFLAMMATION; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCOPOLYSACCHARIDOSIS III; TH2 CELLS; TREATMENT OUTCOME;

EID: 67650886043     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21949     Document Type: Conference Paper

References (38)

1. Alessandri B, Rice AC, Levasseur J, DeFord M, Hamm RJ, Bullock MR. 2002. Cyclosporin A improves brain tissue oxygen consumption and learning/ memory performance after lateral fluid percussion injury in rats. J Neurotrauma 19:829-841.
2. Bachstetter A, Pabon MM, Cole MJ, Hudson CE, Sanberg PR, Willing AE, Bickford PC, Gemma C. 2008. Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci 9:22.
3. Beesley C, Young EP, Vellodi A, Winchester BG. 1998. Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB). J Med Genet 35:910-914.
4. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. 2001. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682-2688.
5. Di Natale P, Di Domenico C, Gargiulo N, Castaldo S, Gonzalez Y Reyero E, Mithbaokar P, De Felice M, Follenzi A, Naldini L, Villani GR. 2005. Treatment of the mouse model of mucopolysaccharidosis type IIIB with lentiviral-NAGLU vector. Biochemistry 338:639-646.
6. Farndale R, Buttle DJ, Barrett AJ. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883:173-177.
7. Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC, Hudson JE, Chen N, Davis CD, Sanberg PR. 2003. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 12:255-270.
8. Garbuzova-Davis S, Willing AE, Desjarlais T, Davis Sanberg C, Sanberg PR. 2005. Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B. Stem Cells Dev 14:384-394.
9. Garbuzova-Davis S, Gografe SJ, Sanberg CD, Willing AE, Saporta S, Cameron DF, Desjarlais T, Daily J, Kuzmin-Nichols N, Chamizo W, Klasko SK, Sanberg PR. 2006. Maternal transplantation of human umbilical cord blood cells provides prenatal therapy in Sanfilippo type B mouse model. FASEB 20:485-487.
10. Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, Willing AE, Gemma C, Bickford PC, Miller C, Rossi R, Sanberg PR. 2008. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS ONE 3:e2494.
11. Li H, Yu WH, Rozengurt N, Zhao HZ, Lyons KM, Anagnostaras S, Fanselow MS, Suzuki K, Vanier MT, Neufeld EF. 1999. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci USA 96: 14505-14510.
12. Li H, Zhao HZ, Neufield EF, Cai Y, Gomez-Pinilla F. 2003. Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo Syndrome type B. Neurosci Res 69:30-38.
13. Lu D, Sanberg PR, Mahmood A, Li Y, Wang L, Sanchez-Ramos J, Chopp M. 2002. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 11:275-281.
14. Mayani H, Lansdorp PM. 1998. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 16:153-165.
15. McIntyre C, Derrick Roberts AL, Ranieri E, Clements PR, Byers S, Anson DS. 2008. Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA. Mol Genet Metab 93:411-418.
16. Morris R. 1995. Mechanisms of action of new immunosuppressive drugs. Ther Drug Monit 17:564-569.
17. Nayar B, Raju GM, Deka D. 2002. Hematopoietic stem/progenitor cell harvesting from umbilical cord blood. Int J Gynaecol Obstet 79:31-32.
18. Neufeld E, Muenzer J. 1995. The mucopolysaccharidoses. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. p 2465-2494.
19. Newcomb JD, Sanberg PR, Klasko SK, Willing AE. 2007. Umbilical cord blood research: current and future perspectives. Cell Transplant 16: 151-158.
20. Nikolic WV, Hou H, Town T, Zhu Y, Giunta B, Sanberg CD, Zeng J, Luo D, Ehrhart J, Mori T, Sanberg PR, Tan J. 2008. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev 17:423-440.
21. Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF. 2003. Activated microglia in cortex of mouse models of mucopolysac-charidoses I and IIIB. Proc Natl Acad Sci U S A 100:1902-1907.
22. Okonkwo D, Büki A, Siman R, Povlishock JT. 1999. Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 10:353-358.
23. Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, Saunders EF, deAlarcon PA, Twist C, Nachman JB, Hale GA, Harris RE, Rozans MK, Kurtzberg J, Grayson GH, Williams TE, Lenarsky C, Wagner JE, Krivit W. 1998. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 91:2601-2108.
24. Sanchez-Ramos JR. 2002. Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 69:880-893.
25. Sanchez-Ramos JR, Song S, Kamath SG, Zigova T, Willing A, Cardozo-Pelaez F, Stedeford T, Chopp M, Sanberg PR. 2001. Expression of neural markers in human umbilical cord blood. Exp Neurol 171:109-115.
26. Saporta S, Kim JJ, Willing AE, Fu ES, Davis CD, Sanberg PR. 2003. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res 12:271-278.
27. Shapiro E, Lockman LA, Balthazor M, Krivit W. 1995. Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 18:413-429.
28. Shiga Y, Onodera H, Matsuo Y, Kogure K. 1992. Cyclosporin A protects against ischemia-reperfusion injury in the brain. Brain Res 595:145-148.
29. Staba S, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P, Allison-Thacker J, Wood S, Wenger DA, Rubinstein P, Hopwood JJ, Krivit W, Kurtzberg J. 2004. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 350:1960-1969.
30. Sullivan P, Thompson M, Scheff SW. 2000. Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury. Exp Neurol 161:631-637.
31. Todaro AM, Pafumi C, Pernicone G, Munda S, Pilastro MR, Russo A, Farina M, Messina A. 2000. Haematopoietic progenitors from umbilical cord blood. Blood Purif 18:144-147.
32. Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE. 2005. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 14:595-604.
33. Weber B, Blanch L, Clements PR, Scott HS, Hopwood JJ. 1996. Cloning and expression of the gene involved in Sanfilippo B syndrome (mucopolysac-charidosis III B). Hum Mol Genet 5:771-777.
34. Weber B, Guo XH, Kleijer WJ, van de Kamp JJ, Poorthuis BJ, Hopwood JJ. 1999. Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Eur J Hum Genet 7:34-44.
35. Yoshimoto T, Siesjö BK. 1999. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res 839:283-291.
36. Zheng Y, Rozengurt N, Ryazantsev S, Kohn DB, Satake N, Neufeld EF. 2003. Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow. Mol Genet Metab 79:233-244.
37. Zheng Y, Ryazantsev S, Ohmi K, Zhao HZ, Rozengurt N, Kohn DB, Neufeld EF. 2004. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB. Mol Genet Metab 82:286-295.
38. Zigova T, Song S, Willing AE, Hudson JE, Newman MB, Saporta S, Sanchez-Ramos J, Sanberg PR. 2002. Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplant 11:265-274.